JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, D.
Right arrow Articles by Behr, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, D.
Right arrow Articles by Behr, M. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2003, p. 2878-2883, Vol. 41, No. 7
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.7.2878-2883.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Widespread Pyrazinamide-Resistant Mycobacterium tuberculosis Family in a Low-Incidence Setting

Dao Nguyen,1,2 Paul Brassard,1,3 Jennifer Westley,2 Louise Thibert,4 Melanie Proulx,3 Kevin Henry,5 Kevin Schwartzman,1,6 Dick Menzies,1,6 and Marcel A. Behr1,2*

Department of Medicine,1 Research Institute, McGill University Health Centre,2 Department of Epidemiology and Biostatistics,3 Department of Geography,5 Respiratory Epidemiology Unit, McGill University,6 Laboratoire de Santé Publique du Québec, Montreal, Quebec, Canada4

Received 7 January 2003/ Returned for modification 3 March 2003/ Accepted 27 March 2003

An unusually high prevalence of pyrazinamide (PZA) monoresistance in Mycobacterium tuberculosis has been observed in Quebec. In the absence of a recognized outbreak, we hypothesized that these isolates most likely represented reactivation of an old endemic strain in this low-incidence area. A case-control study of 77 PZA-resistant isolates with a specific Quebec mutation and 253 PZA-susceptible control M. tuberculosis isolates was undertaken. By molecular analysis, all 77 case isolates shared a unique mutation profile in the pncA gene which was not present in control isolates. While control isolates manifested diverse IS6110 restriction fragment length polymorphism (RFLP) patterns, spoligotypes, and major genetic groups, case isolates had similar but nonidentical IS6110 RFLP patterns, had common spoligotypes, and were confined to one major genetic group, suggesting a common clonal ancestor. By epidemiologic and geographic analyses, however, there were no significant differences between the cases and the controls. We conclude that a clonally related family of PZA-monoresistant M. tuberculosis isolates in Quebec represents historic rather than recent transmission.


* Corresponding author. Mailing address: Division of Infectious Diseases and Microbiology, A5.156, Montreal General Hospital, 1650 Cedar Ave., Montreal, H3G 1A4, Quebec, Canada. Phone: (514) 934-1934, ext. 42815. Fax: (514) 934-8423. E-mail: marcel.behr{at}mcgill.ca.


Journal of Clinical Microbiology, July 2003, p. 2878-2883, Vol. 41, No. 7
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.7.2878-2883.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.